Suppr超能文献

非小细胞肺癌合并内脏胸膜侵犯患者肺内淋巴结的作用。VPI 1314 多中心注册研究方案。

Role of intrapulmonary lymph nodes in patients with NSCLC and visceral pleural invasion. The VPI 1314 multicenter registry study protocol.

机构信息

Division of Thoracic Surgery, Cantonal Hospital Lucerne, Lucerne, Switzerland.

Division of Thoracic Surgery, IRCSS Azienda Ospedaliero-Universitaria, Bologna, Italy.

出版信息

PLoS One. 2023 May 4;18(5):e0285184. doi: 10.1371/journal.pone.0285184. eCollection 2023.

Abstract

BACKGROUND

In the lung cancer classification (TNM), the involvement of thoracic lymph nodes is relevant from a diagnostic and prognostic point of view. Even if imaging modality could help in selecting patients who should undergo surgery, a systematic lymph node dissection during lung surgery is mandatory to identify the subgroup of patients who can benefit from an adjuvant treatment.

METHODS

Patients undergoing elective lobectomy/bilobectomy/segmentectomy) for non-small cell lung cancer and lymphadenectomy with lymph nodes station 10-11-12-13-14 sampling that meet the inclusion and exclusion criteria will be recorded in a multicenter prospective database. The overall incidence of N1 patients (subclassified in: Hilar Lymph nodes, Lobar Lymph nodes and Sublobar Lymph nodes) will be examined as well as the incidence of visceral pleural invasion.

DISCUSSION

The aim of this multicenter prospective study is to evaluate the incidence of intrapulmonary lymph nodes metastases and the possible relation with visceral pleural invasion. Identifying patients with lymph node station 13 and 14 metastases and/or a link between visceral pleural invasion and presence of micro/macro metastases in intrapulmonary lymph nodes may have an impact on decision-making process.

TRIAL REGISTRATION

ClinicalTrials.gov ID: NCT05596578.

摘要

背景

在肺癌分类(TNM)中,胸内淋巴结的累及从诊断和预后的角度来看都是相关的。即使影像学检查可以帮助选择需要手术的患者,但在肺手术中进行系统性淋巴结清扫是确定可以从辅助治疗中获益的患者亚组的必要条件。

方法

将符合纳入和排除标准的行择期肺叶切除术/双肺叶切除术/肺段切除术的非小细胞肺癌患者和淋巴结站 10-11-12-13-14 取样的淋巴结切除术患者记录在一个多中心前瞻性数据库中。将检查 N1 患者(分类为:肺门淋巴结、肺叶淋巴结和亚肺叶淋巴结)的总发生率,以及内脏胸膜侵犯的发生率。

讨论

这项多中心前瞻性研究的目的是评估肺内淋巴结转移的发生率以及与内脏胸膜侵犯的可能关系。确定淋巴结站 13 和 14 转移的患者和/或内脏胸膜侵犯与肺内淋巴结微/Macro 转移之间的关系,可能会对决策过程产生影响。

试验注册

ClinicalTrials.gov ID:NCT05596578。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77f6/10159114/77e5c5c9d7d0/pone.0285184.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验